Differentiation of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii from diarrhoeic stools using Polymerase Chain Reaction in Kaduna, Nigeria by Dawah, I.S. et al.
International Journal of Medicine and Biomedical Research 
Volume 5 Issue 2 May – August 2016 
www.ijmbr.com 
© Dawah et al.; licensee Michael Joanna Publications  
 
Original Article  Open Access 
 
 This is an Open Access article distributed under the terms of the creative commons Attribution 4.0 licence 
(http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited. 
Differentiation of Entamoeba histolytica, Entamoeba dispar and 
Entamoeba moshkovskii from diarrhoeic stools using 
Polymerase Chain Reaction in Kaduna, Nigeria 
 
Dawah I.S*, Inabo H.I, Abdullahi I.O and Machido A.D 
 
Department of Microbiology, Ahmadu Bello University, Zaria, Nigeria 
 
*Corresponding author: dawailiyah@yahoo.com 
 




The protozoan parasite Entamoeba histolytica is 
estimated to infect 50 million people and causes 
40,000 to 100,000 deaths annually, making it the 
third leading parasitic cause of death worldwide.[1] 
Other Entamoeba species, such as E. dispar and 
E. moshkovskii, have also been found in patients 
ABSTRACT 
Background: Entamoeba species have been reported to cause a high morbidity and 
mortality rate. Aim: The study was aimed at detecting and differentiating E. histolytica, E. 
dispar and E. moshkovskii using molecular technique (PCR). Methods: Microscopic 
examination of the faecal samples was carried out by the Formol-Ether concentration 
technique. DNA was extracted from microscopic positive stool samples and used to 
amplify a part of the genus Entamoeba small-subunit ribosomal RNA gene (SSU rDNA), 
using the Nested Multiplex Polymerase Chain Reaction (NM-PCR). Results: Of the 528 
faecal samples, 46 (8.7%) were positive for Entamoeba by microscopy. The PCR results 
showed that out of the 46 microscopy positive samples, 16 (34.8%) successfully 
generated species-specific amplicons of Entamoeba species DNA. The infection with E. 
dispar (68.8%; 11/46) was the most common, followed by E. histolytica (37.5%; 6/46) 
and E. moshkovskii (18.8%; 3/46). Of these, 7 (43.8%) were shown to contain only E. 
dispar, 3 (18.8%) contained only E. histolytica and 2 (12.5%) contained only E. 
moshkovskii. Mixed infection with E. histolytica and E. dispar was found in 3 (18.8%) and 
E. dispar and E. moshkovskii in 1 (6.3%) sample. Conclusion: This study therefore 
highlighted the great importance of the use of molecular techniques to differentiate 
between E. histolytica, E. dispar and E. moshkovskii because it obviates unnecessary 
chemotherapy with possible costs, side effects and drug resistance. The use of PCR in 
the diagnosis of amoebiasis and epidemiological survey in Nigeria is thus recommended. 
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with gastrointestinal symptoms.[2,3]  However, 
there is as yet no definitive evidence 
demonstrating that these two species are 
pathogenic to humans.[4]  
 
E. histolytica, E. dispar and E. moshkovskii are 
morphologically identical but are biochemically 
and genetically different. Laboratory diagnosis of 
the aetiological agent of diarrhoea/ dysentery is of 
utmost importance for the timely management of 
dysentery cases.[5] Routine microscopic 
examination of stool sample is the most widely 
used technique, but microscopy alone has low 
sensitivity and it is insufficient for differentiation 
among Entamoeba spp. Molecular techniques are 
newer methods currently used for the 
identification of Entamoeba spp.[6]   
 
It is important to emphasize that earlier reports 
have been relying upon results of microscopic 
examination of stool specimens that cannot 
differentiate the pathogenic E. histolytica from the 
morphologically identical species E. dispar and E. 
moshkovskii, which occur worldwide.[7] In previous 
studies, many E. dispar and E. moshkovskii 
infections were most probably confused with E. 
histolytica infections and were unnecessarily 
treated. 
 
In fact, E. dispar is a harmless commensal 
protozoan and its presence in clinical specimens 
does not justify treatment.[8] It has actually been 
established that misidentification of E. histolytica 
infection may occur if the diagnosis is based 
solely on stool microscopy. For final confirmatory 
identification, biochemical techniques, 
immunologic assays for detection of E. histolytica 
antigens or molecular methods are needed.[9]  
 
Amplification of amoeba DNA fragments by PCR 
has proved its usefulness for differential detection 
of E histolytica, E. dispar and E. moshkovskii 
directly from stool samples.[2] Moreover, this PCR-
based approach is suitable for molecular 
epidemiological studies, which have been strongly 
encouraged by the World Health Organization.[8] 
Therefore, the purpose of this study was to obtain 
more reliable and appropriate epidemiological 
data concerning E. histolytica, E. dispar and E. 
moshkovskii infections in diarrhoeic patients 
attending some hospitals in Kaduna State, 




Study area and population 
The present study was carried out in six 
government hospitals. Two hospitals each from 
the three Senatorial Districts in Kaduna State, 
Nigeria, namely: Kafanchan and Kachia General 
Hospitals in the South, Yusuf  Dantsoho General 
Hospital Kaduna and Birnin Gwari General 
Hospital in the Central, Saminaka General 
Hospital and Hajiya Gambo Sawaba Memorial 
Hospital, Zaria in the North. This study was 
conducted between August, 2013 and August, 
2014. A total of 528 diarrheic faecal samples were 
examined for the presence of Entamoeba 
histolytica, Entamoeba dispar and Entamoeba 
moshkovskii infection via a combination of 
microscopy and Nested Multiplex Polymerase 
Chain Reaction (NM-PCR) targeting 16S 
ribosomal RNA of Entamoeba species.   
 
All patients presenting to the selected hospitals 
with acute and persistent diarrhoea or dysentery 
within the period of the study were enlisted having 
consented to participate and fulfilled the inclusion 
criteria which included acute or persistent 
diarrhoea and dysenteric syndrome.  Patients 
without diarrhoea were excluded.  
 
Consent, sample collection and laboratory 
procedures 
The study was approved by the Ethical Committee 
of the Ministry of Health, Kaduna State.  
Description of the objectives and methodology of 
the study was explained to the patients or 
parents/guardians prior to sample collection. Five 
hundred and twenty eight (528) stool samples 
were aseptically collected from the patients at the 
selected hospitals in sterile capped bottles.  
 
Microscopy  
The stool samples were analyzed using the 
Formol-Ether concentration method as described 
by Cheesbrough.[10] Briefly, about 1g of the faecal 
matter was mixed in about 4ml of 10% formol 
water in a screw-cap tube and shaken for about 
20 seconds. The emulsified faeces was sieved 
and the filtrate transferred to a conical centrifuge 
tube with an equal volume of ether. The tube was 
centrifuged for 1 minute at 3000rpm. The faecal 
debris was discarded and the sediment 
transferred to a clean glass slide. After the 
addition of a small amount of iodine, the glass 
slide was covered with a cover slip. The entire 
preparation was microscopically examined under 
x10 objective to identify the cysts. Microscopically 
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positive samples for Entamoeba species were 
stored at -200C prior to DNA extraction. 
DNA extraction 
The DNA extraction of all microscopy-positive samples was carried out using the MagNa Pure 
LC DNA isolation kit (Roche Applied Sciences) 
according to the manufacturer’s instructions. 
Briefly, genomic DNA was lysed in a buffer 
containing guanidine isothiocynate and bound to 
magnetic glass particles under chaotropic 
conditions. The unbound substances and 
impurities were removed by washing the magnetic 
particles. The washed DNA was eluted from the 
magnetic particles under conditions of low salt 
concentration and elevated temperatures. The 
extracted genomic DNA was then stored at -200c 
untill required for PCR amplification.
 
Standard strains 
The standard strains of E. histolytica HM-1: IMSS, 
E. dispar SAW760 and E. moshkovskii Laredo 
strains were used as positive control in this study. 
The lyophilized DNA of these strains was donated 
by C. Graham Clark from the London School of 
Hygiene and Tropical Medicine, London, UK. 
 
NM-PCR 
Nested multiplex PCR targeting 16S-like 
ribosomal RNA gene was used to genetically 
characterize E. histolytica, E. dispar and E. 
moshkovskii according to Ngui et al.[11] Primary 
PCR for the detection of Entamoeba genus used 
forward primer E-1 (5’-TAAGATGCA 
GAGCGAAA-3’) and reverse primer E-2 (5’-
GTACAAAGGGCAGGGACGTA-3’).[11] 
Entamoeba species genomic DNA (positive 
control) was included in each PCR run.[11] The 
PCR was carried out in a 25μl volume with the 
final mix containing 10× PCR buffer, 1.25 mM 
dNTPs, 25 mM MgCl2, 10 pmole of each primer, 
0.3µl of Taq polymerase and 2.5 μl of DNA 
template.[11] The sample was heated to 96°C for 2 
min, followed by 30 cycles of 92° C for 1 min 
(denaturing), 56°C for 1 min (annealing), 72°C for 
1 min 30 s (extension) and a final extension at 
72°C for 7 min.[11] 
 
Subsequently, the primary PCR products were 
subjected to secondary PCR for Entamoeba 
species-specific characterization.[11]  Amplification 
was achieved using primer sets EH-1 (5’-AAG 
CATTGTTTCTAGATCTGAG-3’) and EH-2 (5’-
AAGAGGTCTAACCGAAATTAG-3’) to detect E. 
histolytica (439 bp); ED-1 (5’-
TCTAATTTCGATTAGAACTCT-3’) and ED-2 (5’-
TCCCTACCTATTAGACATAGC-3’) to detect E. 
dispar (174 bp); Mos-1 (5’-GAAACCAAG 
AGTTTCACAAC-3’) and Mos-2 (5’-
CAATATAAGGCTTGGATGAT-3’) to detect E. 
moshkovskii (553 bp). The secondary 
amplification reagent concentrations were similar 
to the first PCR except that 2.5μl of primary PCR 
product was added instead of genomic DNA 
template.[11] 
 
The secondary PCR had a similar cycling 
condition except that the annealing temperature 
(48°C instead of 56°C) and extension duration (1 
min instead of 1 min 30 sec) were modified. In 
both amplifications, samples were incubated in 
the MyCycler thermal cycler (Bio-Rad, Hercules, 
USA).[11]   
 
Agarose gel electrophoresis 
Electrophoresis was used to separate 3µL of the 
amplification products through 1.8% Agarose gel 
in 0.5 x Tris-borate-EDTA at 120V for 45 minutes. 
This was then visualized by ethidium bromide 
staining under uktraviolet light for bands of DNA of 
appropriate sizes. Control reactions were included 
with each batch of samples analyzed by nested 




The data entry and analysis was carried out using 
the SPSS software (Statistical Package for the 
Social Sciences) program for Windows version 17 
(SPSS, Chicago, IL, USA). Qualitative data were 
estimated and presented as frequencies and 
percentage. The prevalence and 95% confidence 
intervals (CIs) were calculated for each parasite. 
Associations between proportions were explored 
using chi-square X2 (test) and a P-value of <0.05 






A total of 528 stool samples were examined 
microscopically for Entamoeba spp. Of these, 46 
(8.7%) samples were diagnosed as Entamoeba 
positive and subjected to PCR for differentiation of 
Entamoeba species. Males were more infected 
(10.8%) than females (6.6%) but the difference 
was not statistically significant (P> 0.05) (result 
not shown).   Out of the 46 microscopy-positive 
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samples, 16 (34.8%) samples successfully 
amplified Entamoeba species DNA by nested 
multiplex PCR. Birnin Gwari had the highest 
prevalence (66.7%), followed by Kafanchan 
(42.9%), Kachia (27.0%), Saminaka (25.0%), 
Kaduna (20.0%), while Zaria (16.7%) had the 
least (table 1). 
 
 
The PCR differentiation of Entamoeba species in 
table 2 revealed that Entamoeba dispar infection  
 
 
appeared to be the most dominant [11 (68.8%)], 
followed by Entamoeba histolytica [6 (37.5%)] and 
Entamoeba moshkovskii [3 (18.8%)]. 
 
Out of the 16 PCR positive samples, 3 (18.8%) 
contained only Entamoeba histolytica, 7 (43.8%) 
contained only Entamoeba dispar and 2 (12.5%) 
contained only Entamoeba moshkovskii. Mixed 
infection with Entamoeba dispar and Entamoeba 
histolytica was found in 3 (18.8%) samples, while 
only 1 (6.3%) sample had Entamoeba dispar and 
Entamoeba moshkovskii as shown in table 3. 
 
 
Table 1: Prevalence of Entamoeba infection based on microscopy and nested multiplex PCR assay of 
faecal samples according to locations 
 
Location NE Microscopy 
 n                     % 
PCR assay 
 n                        *% 
GH Kafanchan 88 7 8.0 3 42.9 
YDGH Kaduna 88 5 5.7 1 20.0 
GH Kachia 88 11 12.5 3 27.0 
HGSGH Zaria 88 6 6.8 1 16.7 
GH Saminaka 88 8 9.1 2 25.0 
GH Birni Gwari 88 9 10.2 6 66.7 
Total 528 46 8.7 16 34.8 
Key:  NE= Number Examined, n = Number positive, *= based on number positive by microscopy, YD= 





Table 2: Differentiation of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii as 








E. dispar E. moshkovskii 
n % n % n % 
GH Kafanchan 3 2 66.7 2 66.7 1 33.3 
YDGH Kaduna 1 0 0 1 100 0 0 
GH Kachia 3 1 33.3 2 66.7 0 0 
HGSGH Zaria 2 1 50 1 50 1 50 
GH Saminaka 2 1 50 2 100 0 0 
GH Birnin Gwari 5 1 20 3 60 1 20 
Total 16 6 37.5 11 68.8 3 18.8 
Key:  GH = General Hospital, YD = Yusuf Dantsoho, HGS = Hajiya Gambo Sawaba, NP PCR = Number 
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Table 3: Pattern of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii infection as 
determined by nested multiplex PCR in microscopically positive samples 
 
 
Type of infection 
No. of samples positive 
by PCR 
Percentage of stool  
positive (%) 
E. histolytica (mono infection) 3 8.8 
E. dispar (mono infection) 7 43.8 
E. moshkovskii (mono infection) 2 12.5 
E. dispar + E. histolytica (mixed) 3 18.8 
E. dispar + E. moshkovskii (mixed) 1 6.3 
Total  16 100 




The results of this study revealed that of the 46 
microscopy-positive samples, 16 (34.8%) samples 
successfully amplified Entamoeba species DNA 
by nested multiplex PCR. Our molecular 
differentiation of Entamoeba species showed that 
Entamoeba dispar (68.8%) was observed to be 
the commonest species detected in this study, 
followed by Entamoeba histolytica (37.5%) and 
Entamoeba moshkovskii (18.8%). The high 
prevalence of E. dispar in the present study 
agreed with the worldwide distribution of 
Entamoeba species, which indicated that 
Entamoeba dispar is perhaps 10 times more 
common than Entamoeba histolytica,[12] however, 
the local prevalence may vary significantly, thus 
necessitating the assessment of prevalence in 
different in  geographical regions. Similar 
observation also reported that 70.8% of patients 
were infected with E. dispar, compared to 4.5% of 
E. histolytica and 61.8% of E. moshkovskii in 
Australia.[2] 
 
A study in Brazil showed that the prevalence of 
Entamoeba dispar (90%) was more frequent 
compared to Entamoeba histolytica (10%) among 
infected individuals.[13] Also a study in India 
showed similar findings, where 49.5% patients 
were infected with Entamoeba dispar and only 
7.4% with Entamoeba histolytic,[14] while another 
study in Netherlands reported 91.2% 
microscopically positive samples were identified 
as Entamoeba dispar and 6.7% were Entamoeba 
histolytica by both PCR and ELISA assay.[15] 
 
This study also showed that 7 (43.8%) contained 
only Entamoeba dispar, 3 (18.8%) contained only 
Entamoeba histolytica and 2 (12.5%) contained 
only Entamoeba moshkovskii. Mixed infection with 
Entamoeba dispar and Entamoeba histolytica was 
found in 3 (18.8%) samples, while only 1 (6.3%) 
sample had Entamoeba dispar and Entamoeba 
moshkovskii. This result is consistent  with that of 
Ngui and co-workers who reported 33 (65.5%) 
samples contained only E. histolytica, 10 (19.2%) 
contained only E. dispar and 3 (5.8%) contained 
only E. moshkovskii. Mixed infection with E. 
histolytica and E. dispar was found in 6 (11.5%) 
samples.[11] 
 
The detection of E. moshkovskii (18.8%) in this 
study, to the best of our knowledge, was the first 
to be reported in Kaduna State, Nigeria. Many 
cases of humans infected with E. moshkovskii 
have been reported sporadically from different 
parts of the world including Thailand,[16] India,[17] 
and Australia.[2] Another study in India highlighted 
that E. moshkovskii infection was associated with 
dysentery.[17] In our study, it was noted that all 
individuals infected with E. moshkovskii were 
children and were symptomatic. Therefore, further 
investigation which includes the clinical impact of 
E. moshkovskii is imperative for a better 






The nested multiplex polymerase chain 
reaction (NM-PCR) method was effective in 
differentiating E. histolytica from E. dispar and 
E. moshkovskii. The NM-PCR method is an 
optional tool in the diagnosis and 
epidemiological studies of amoebiasis. The 
correct detection and differentiation of E. 
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histolytica from E. dispar and E. moshkovskii 
will avoid unnecessary treatment of E. dispar 
or E. moshkovskii-infected patients with anti-
amoebic drugs. We propose the use of PCR in 
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